Register | Login or

General Information

Websiteschering.de
CategoryBioTech
Phone+49 30 468 1111
Employees
Descriptionbiopharmaceutical

Offices

Former People

Board of Executive Directors

Investments

Tags

Schering

As a successful pharmaceutical company, Schering are investing in the future of medicine. They develop drugs of high medical value so as to continuously improve the quality of life.

Using interdisciplinary networks we build bridges to academic researchers around the world, as well as to highly specialized biotech pioneers and partners in the pharmaceutical industry. They combine their own longstanding medical and pharmaceutical expertise with the latest discoveries from genomic research.

Schering focuses on chosen fields of expertise:

Gynecology & Andrology Oncology Diagnostic Imaging Specialized Therapeutics As a global player with over 140 subsidiaries they are in close contact with our customers around the world.

Milestones

Videos

Screenshots

Sources

  1. Anacor Raises $50 Million in Equity Financing (bio-medicine.org) [edit]
  2. Anacor, anti-fungal therapy co., gets $50M from Schering-Plough (deals.venturebeat.com) [edit]
Edit This Page
Last Edited 12/22/11

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy